期刊文献+

肥胖与哮喘的研究进展 被引量:1

Research progress of obesity and asthma
下载PDF
导出
摘要 哮喘是一种慢性疾病,目前已从遗传基因、脂肪因子、炎性损伤、肥胖相关并发疾病等方面提出了各种假说以解释肥胖与哮喘的关系,但机制尚不明确。肥胖与哮喘仍是研究人员感兴趣的话题,本文综述了肥胖与哮喘之间的最新研究进展,以期为临床提供参考。 Asthma is a chronic disease.In present, a variety of hypotheses have been proposed to elucidate the relationship between obesity and asthma, including genetic factors, adipokines, inflammatory injury, and obesity related diseases, but the underlying mechanism remains unclear.The relationship of obesity and asthma is still a topic of interest to researchers.This article reviewed the latest researches on their relationship, in order to provide reference for clinical practice.
作者 倪玲 吴晓梅
出处 《中华老年多器官疾病杂志》 2017年第5期398-400,共3页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 肥胖 哮喘 机制 治疗 进展 obesity asthma mechanism treatment progress
  • 相关文献

参考文献1

二级参考文献16

  • 1朱雪琦,刘清泉,姚咏明.脓毒症动物模型制备方法的研究进展[J].中国危重病急救医学,2006,18(2):114-116. 被引量:30
  • 2Annane D, Bellissant E, Cavaillon JM. Septic shock[J]. Lancet, 2005, 365(9453): 63-78.
  • 3Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003[J]. Crit Care Med, 2007, 35(5): 1244-1250.
  • 4Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis[J]. Crit Care Med, 2006, 34(1): 15-21.
  • 5Rudiger A, Singer M. Mechanisms of sepsis-induced cardiac dysfunction[J]. Crit Care Med, 2007, 35(6): 1599-1608.
  • 6Parrilo JE, Parker MM, Natanson C, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy[J]. Ann Intern Med, 1990, 113(3): 227-242.
  • 7Vieillard-Baron A, Caille V, Charron C, et al. Actual incidence of global left ventricular hypokinesia in adult septic shock[J]. Crit Care Med, 2008, 36(6): 1701-1706.
  • 8Duan SZ, Usher MG, Mortensen RM. PPARs: the vasculature, inflammation and hypertension[J]. Curr Opin Nephrol Hypertens, 2009, 18(2): 128-133.
  • 9Gervois P, Fruchart JC, Staels B. Drug insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors[J]. Nat Clin Pract Endocrinol Metab, 2007, 3(2): 145-156.
  • 10Di Paola R, Esposito E, Mazzon E, et al. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan[J]. Shock, 2006, 26(5): 477-484.

同被引文献8

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部